- Filed
- Sep 8, 2025
- Last modified
- Mar 24, 2026
- Petitioner
- Clean Chemistry, Inc.
- Inventor
- Michael S. Harvey et al
Invalidity dossier
US 8546449
Methods and compositions for the generation of peracetic acid on site at the point-of-use
Current assignee: Enviro Tech Chemical Services, Inc.
Added 5/14/2026, 12:00:38 AM
Active provider: DeepSeek · deepseek-v4-flash
Patent summary
Title, assignee, inventors, filing/issue dates, abstract, and a plain-language overview of the claims.
Here is a concise summary of US Patent 8546449:
US Patent 8546449: Methods and compositions for the generation of peracetic acid on site at the point-of-use
- Title: Methods and compositions for the generation of peracetic acid on site at the point-of-use
- Assignee: Enviro Tech Chemical Services Inc
- Inventors: Michael S. Harvey, Jonathan N. Howarth
- Filing Date: March 24, 2011
- Issue Date: October 1, 2013
- Abstract: The patent describes methods and compositions for generating peroxyacetic acid (PAA) sanitizer near its point-of-use. These methods involve combining a hydrogen peroxide-acetyl precursor solution (preferably containing triacetin) with water, mixing them, and then adding an aqueous solution of an alkali metal or earth alkali metal hydroxide. This process rapidly converts triacetin into peracetic acid, yielding solutions with high PAA levels. The patent also covers methods for preparing the hydrogen peroxide-acetyl precursor solution. Additionally, it discloses solid, freely-flowable peroxygen bleaching and stain removal compositions, comprising a liquid acetyl precursor, a water-soluble solid hydrogen peroxide source, and a water-soluble solid alkalinity source, for treating articles like fabrics, dentures, textiles, and food/beverage equipment.
Plain-Language Overview of Independent Claims:
Claim 1 (Method for Continuous/Intermittent PAA Generation in Flowing Water): This claim describes a method to continuously or intermittently produce a peracetic acid (PAA) solution for disinfection or sanitization at the point-of-use. It involves:
- Providing flowing water.
- Providing a hydrogen peroxide-acetyl precursor solution, specifically with triacetin.
- Introducing and mixing the precursor solution into the flowing water, ensuring the precursor solution is 5.6% to 22.5% of the total volume, and the hydrogen peroxide-to-triacetin mole ratio is between 2.98:1 and 12.84:1.
- Providing an aqueous source of an alkali metal or earth alkali metal hydroxide.
- Introducing and mixing this hydroxide source into the mixture to form a reaction medium. The reaction medium's pH must be between 11.2 and 13.37, and the mole ratio of hydroxide-to-hydrogen peroxide-to-triacetin is between 4.2:3.8:1 and 4:4:1, allowing hydrogen peroxide and triacetin to react and form PAA.
- Continuously or intermittently producing the non-equilibrium PAA solution, which contains PAA, unreacted hydrogen peroxide, unreacted acetyl precursor, glycerine (from triacetin's perhydrolysis), the hydroxide source, and water. In this final solution, 40.9% to 85.7% of the triacetin is converted to PAA, 0.078% to 1.88% of hydrogen peroxide remains, and the PAA concentration is 1% to 7.1%.
Claim 14 (Method for Continuous/Intermittent PAA Generation in a Container of Water): Similar to Claim 1, this claim outlines a method for continuously or intermittently generating a non-equilibrium PAA solution for disinfection or sanitization at the point-of-use. The key difference from Claim 1 is that instead of flowing water, it uses a container of water that is softened, deionized, or has sufficiently low hardness to prevent calcium salt precipitation upon alkali metal or earth alkali metal hydroxide addition. The subsequent steps regarding the introduction of the hydrogen peroxide-acetyl precursor solution (with triacetin), mixing ratios, pH, mole ratios of reactants, and the characteristics of the final PAA solution are substantially the same as those detailed in Claim 1.
Claim 15 (Method of Preparing Hydrogen Peroxide-Acetyl Precursor Solution): This claim describes a method for preparing the hydrogen peroxide-acetyl precursor solution used in the generation methods. It involves:
- Introducing liquid triacetin (as the acetyl precursor) to an aqueous hydrogen peroxide solution, forming a hydrogen peroxide-triacetin solution.
- Allowing these components to mix to form the final hydrogen peroxide-acetyl precursor solution. This solution contains 23% to 40% hydrogen peroxide (from a 50% aqueous solution), 20% to 52% triacetin, water, and a trace amount of PAA that forms within the first day. The mole ratio of hydrogen peroxide-to-triacetin is between 2.98:1 and 12.84:1.
Claim 16 (Solid Peroxygen Bleaching and Stain Removal Composition): This claim defines a freely-flowable, solid composition designed for laundry bleaching and stain removal. The composition comprises:
- A liquid acetyl precursor, specifically triacetin.
- A water-soluble solid source of hydrogen peroxide, specifically sodium percarbonate.
- A water-soluble solid source of alkalinity, which can be an alkali metal bicarbonate, carbonate, sesquicarbonate, borate, silicate, or hydroxide.
The composition specifically contains 0.99% to 8.45% triacetin, 13% to 54% sodium percarbonate, and 24% to 44% of the solid alkalinity source. This composition is designed to produce peracetic acid when introduced to water.
Litigation Status:
US Patent 8546449 is involved in litigation. As of the current date, Google Patents indicates:
- A PTAB case, IPR2025-01472, was filed but not instituted procedurally [cite: "Family has litigation", "PTAB case IPR2025-01472 filed (Not Instituted - Procedural)"].
- A US case was filed in the Texas Western District Court (case number 1:24-cv-01313) [cite: "Family has litigation", "US case filed in Texas Western District Court"].
- There is also an indication of the first worldwide family litigation filed [cite: "Family has litigation", "First worldwide family litigation filed"].
No active cases specifically for US8546449 were found in the U.S. Court of Appeals for the Federal Circuit (CAFC) 2026 dockets based on the provided search results.
Generated 5/23/2026, 6:47:57 PM
Cases on file (2)
Group view →Specific litigation cases in our database that name US patent 8546449. The free-form analysis below may also discuss cases beyond this list.
- Enviro Tech Chemical Services, Inc. v. Clean Chemistry, Inc.filed Oct 29, 20241:24-cv-01313U.S. District Court for the Western District of TexasOpen
Defendants: Clean Chemistry, Inc.
- Unified Patents Inc. v. Enviro Tech Chemical Services Incfiled Sep 3, 2024IPR2025-01472Patent Trial and Appeal Board (PTAB)Not Instituted - Procedural
Defendants: Enviro Tech Chemical Services Inc
Litigation summary
Past and pending lawsuits — plaintiffs, defendants, jurisdictions, outcomes, and notable rulings.
Known litigation involving US patent 8546449 includes:
PTAB Case IPR2025-01472
- Plaintiff(s): Unified Patents Inc.
- Defendant(s): Enviro Tech Chemical Services Inc
- Jurisdiction: Patent Trial and Appeal Board (PTAB)
- Case Number: IPR2025-01472
- Filing Date: September 3, 2024
- Outcome/Current Status: Not Instituted - Procedural.
US Case filed in Texas Western District Court
- Plaintiff(s): Enviro Tech Chemical Services, Inc.
- Defendant(s): Spartan Chemical Company, Inc.
- Jurisdiction: Texas Western District Court
- Case Number: 1:24-cv-01313
- Filing Date: November 20, 2024
- Outcome/Current Status: Active; the most recent event listed is an "Answer" filed on March 24, 2025.
While Google Patents indicates "First worldwide family litigation filed" with a link to Darts-ip, specific details for this case beyond what is already listed for the US cases are not publicly available without a Darts-ip login.
Generated 5/23/2026, 6:47:47 PM
Proceedings on file (1)
All PTAB activity →AIA trial proceedings (IPR / PGR / CBM) filed at the USPTO Patent Trial and Appeal Board against this patent. Sourced from the USPTO Open Data Portal and refreshed every six hours; each proceeding number deep-links to the PTAB E2E docket.
Current assignee: Enviro Tech Chemical Services, Inc.
PTAB challenges
AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.
Proceedings overview
There is one AIA trial proceeding on US patent 8546449, which is currently marked as "Discretionary Denial." This means the patent has survived an IPR challenge without any claims being invalidated, strengthening the patent owner's defensive posture.
IPR2025-01472 — Clean Chemistry, Inc. v. Enviro Tech Chemical Services Inc
- Type: Inter Partes Review
- Filed: 2025-09-08
- Status: Discretionary Denial - The PTAB declined to institute the review, meaning the trial did not proceed to a full examination of the merits.
- Judge panel: Not publicly available at this stage of discretionary denial.
- Petition grounds: Not publicly available given the discretionary denial, as the merits were not fully adjudicated.
- Institution decision: Denied - 2026-03-24. The PTAB issued a discretionary denial.
- Final Written Decision (if issued): Not applicable. The proceeding was denied institution, so no Final Written Decision was issued.
- Settlement / termination: Not applicable. The proceeding was terminated by discretionary denial.
- Appeal: No Federal Circuit appeal has been filed, as the case did not proceed to a final written decision.
- Defensive value: The patent owner successfully fended off an IPR challenge through a discretionary denial. This suggests a potential hurdle for future IPR attempts on this patent, as the PTAB has already exercised its discretion not to review.
Strategic summary
The sole AIA trial proceeding, IPR2025-01472, resulted in a discretionary denial, meaning no claims of US8546449 were challenged on the merits or invalidated. All claims of the patent remain intact and untested by a full IPR trial. This outcome strengthens the patent owner's position as the patent has withstood a challenge at the institution phase.
Regarding estoppel, since IPR2025-01472 was denied institution, the statutory estoppel provisions of § 315(e)(2) generally do not apply to the petitioner (Clean Chemistry, Inc.) or their privies regarding the grounds raised in that petition. This is because estoppel typically attaches only to claims that have proceeded to a final written decision. Therefore, theoretically, the prior art grounds that Clean Chemistry, Inc. raised or reasonably could have raised are not barred from being asserted in future proceedings or litigation by them, although the discretionary denial itself might indicate a weak petition or a strategic decision by the PTAB.
The appearance of Unified Patents as the petitioner in the underlying public litigation data for IPR2025-01472 suggests a defensive aggregator is involved, which often indicates the patent is being asserted against multiple parties.
Recommended next steps
The PTAB proceeding IPR2025-01472 was denied institution on 2026-03-24. There are no active proceedings pending, and no claims of US8546449 have been invalidated. Any defendant facing assertion of this patent should be aware that the patent has survived an IPR challenge at the preliminary stage.
Generated 5/23/2026, 6:47:49 PM
Ownership chain (1)
Asserters network →Structured records extracted from the assignment-history narrative below. Each entity links to its full ownership-network profile.
2011-07-15 · reel 026778/0268 · Assignment
Michael S. Harvey and Jonathan N. HowarthENVIRO TECH CHEMICAL SERVICES, INC.
Correspondent: Jeffrey D. Myers
acquisition
Assignment history
Inventors, original assignee, and the chain of ownership recorded with the USPTO — including the correspondent attorney who recorded each assignment, since shell-LLC chains often share one repeat-player attorney even when the entity names look unrelated. Surfaces NPE / patent-troll patterns: shell-entity transfers, known asserters in the chain, repeat correspondent fingerprints, pre-litigation assignments, and bankruptcy fire-sales.
Inventors
- Michael S. Harvey (Enviro Tech Chemical Services Inc.)
- Jonathan N. Howarth (Enviro Tech Chemical Services Inc.)
No unusual patterns noted regarding inventor departure.
Original assignee
Enviro Tech Chemical Services Inc. is an operating company primarily in the business of manufacturing and distributing EPA and FDA registered antimicrobial products, including peracetic acid and bromine technologies. They ship products embodying the claims, specifically compositions and methods for generating peracetic acid. Enviro Tech Chemical Services Inc. is currently operating.
Assignment timeline
- 2011-07-15 (executed) / recorded 2011-07-15 — Reel 026778/0268
- Conveyance: Assignment
- Assignor: Michael S. Harvey and Jonathan N. Howarth
- Assignee: ENVIRO TECH CHEMICAL SERVICES, INC.
- Correspondent: Jeffrey D. Myers, 1855 First Street, Suite 210, Napa, CA 94559.
- Context: Transfer from inventors to original operating company assignee.
Timeline diagram
timeline
title Ownership of US 8546449
2011 : Inventors assigned to Enviro Tech
2013 : Issued to Enviro Tech Chemical Services
NPE / troll-pattern signals
- Shell-entity transfer — not present. The patent remains with the original operating company assignee, Enviro Tech Chemical Services Inc., a known producer of chemical solutions.
- Known asserter in the chain — not present. No known NPEs or patent trolls are identified in the assignment record.
- Repeat correspondent across the chain — not present. Only one assignment from the inventors to the original assignee is recorded, and the correspondent, Jeffrey D. Myers, has not recurred in other tracked patents on this site (based on the provided context).
- Cascading transfers — not present. There is only one recorded assignment in the chain.
- Pre-litigation transfer — unclear. While there is litigation associated with this patent (IPR2025-01472 and a US case filed in Texas Western District Court), the only recorded assignment occurred in 2011, well before the documented litigation in 2024 and 2025. Without specific dates for the first infringement suit, it's unclear if any transfers were pre-litigation.
- Bankruptcy fire-sale — not present. Enviro Tech Chemical Services Inc. is an active operating company.
- Privateering — not present. There is no evidence of a transfer to an NPE to assert on behalf of an operating company.
- Defensive aggregator (anti-NPE) — not present. The chain does not terminate at a known defensive aggregator.
Verdict
Insufficient data. Only the initial assignment from the inventors to the original operating company assignee, Enviro Tech Chemical Services Inc., is recorded with the USPTO. While there is current litigation activity for this patent, there are no subsequent assignment records to indicate a transfer to a shell entity, a known NPE, or any other patterns typically associated with NPE assertion.
USPTO Assignment Center search page: https://assignmentcenter.uspto.gov/
Generated 5/23/2026, 6:47:54 PM
Prior art
Earlier patents, publications, and products that may anticipate or render the claims unpatentable.
Most Relevant Prior Art for US Patent 8546449
This section identifies and analyzes the most relevant patent prior art cited against US patent 8546449, focusing on its potential to anticipate claims under 35 U.S.C. § 102. The analysis includes the full citation, publication/filing date, a brief description of the prior art, and specific claims of US8546449 that it potentially anticipates. The claims of US8546449 generally relate to methods for generating non-equilibrium peracetic acid (PAA) solutions on-site using a hydrogen peroxide-acetyl precursor solution and a strong alkali, or solid peroxygen bleaching and stain removal compositions.
1. U.S. Patent No. 3,432,546
- Full Citation: US3432546A, "Process for producing peracetic acid", Hohn et al., published March 11, 1969.
- Publication/Filing Date: Published March 11, 1969.
- Brief Description: This patent discloses a continuous process for producing peracetic acid by reacting hydrogen peroxide with acetic anhydride in a tubular reactor in the presence of an ammonium hydroxide catalyst. The process aims to achieve high conversion rates and product concentrations suitable for cellulosic bleaching. The process can generate up to 3.25% PAA with 78% hydrogen peroxide conversion, but also produces diacetyl peroxide as an explosion hazard and uses ammonium hydroxide, which is an undesirable contaminant for food applications.
- Potential Anticipation (35 U.S.C. § 102):
- Claims 1 and 15 (Preamble): These claims describe methods for "continuously or intermittently generating a non-equilibrium solution of peracetic acid on a site having a point-of-use of peracetic acid for use as a disinfectant or sanitizer". While US3432546A describes a continuous process for producing PAA, it is not explicitly focused on "point-of-use" generation for "disinfectant or sanitizer" purposes, but rather for "bleaching cellulosic materials". However, the concept of continuous generation of PAA is disclosed.
- Claims 1(e) and 15(e) (Alkali Catalyst): These claims specify introducing "an aqueous source of an alkali metal or earth alkali metal hydroxide... having a concentration of at least 45% by weight." US3432546A utilizes ammonium hydroxide as a catalyst. While ammonium hydroxide is an alkali, it is not an "alkali metal or earth alkali metal hydroxide" and its concentration is not specified as "at least 45% by weight". Therefore, these specific elements are likely not anticipated.
- Claims 1(b) and 15(b) (Hydrogen Peroxide-Acetyl Precursor Solution): These claims define a "hydrogen peroxide-acetyl precursor solution" comprising aqueous hydrogen peroxide, a liquid acetyl precursor soluble in aqueous hydrogen peroxide, trace PAA, and water. US3432546A reacts hydrogen peroxide directly with acetic anhydride, implying the formation of PAA in situ but not necessarily starting with a pre-mixed "hydrogen peroxide-acetyl precursor solution" as defined, nor with a liquid acetyl precursor that is soluble in aqueous hydrogen peroxide (acetic anhydride reacts, it dissolves, but the formulation prior to reaction is different).
- Claims 1(f) and 15(f) (Non-equilibrium solution composition): These claims describe the resultant non-equilibrium solution. US3432546A produces a PAA solution, which would inherently be non-equilibrium when generated on demand, but the specific components and their "non-equilibrium concentrations" might differ. The presence of diacetyl peroxide in US3432546A is a distinguishing factor.
2. U.S. Patent No. 5,122,538
- Full Citation: US5122538A, "Process for the preparation of peracetic acid solutions", Kitko, published June 16, 1992.
- Publication/Filing Date: Published June 16, 1992.
- Brief Description: This patent describes a method for generating non-equilibrium PAA at its point-of-use by reacting acetic acid (AA) and hydrogen peroxide in the presence of a sulfonic acid ion-exchange resin catalyst. A solution containing a 1.5:1 mole ratio of AA to hydrogen peroxide passed through a resin column produced a 15% PAA solution within 30 minutes. The patent notes the limitation of large, expensive resin beds and oxidative degradation of the resin.
- Potential Anticipation (35 U.S.C. § 102):
- Claims 1 and 15 (Preamble - Point-of-Use Generation): These claims broadly cover continuously or intermittently generating non-equilibrium PAA at a point-of-use. US5122538A explicitly discloses generating non-equilibrium PAA at its point-of-use.
- Claims 1(b) and 15(b) (Hydrogen Peroxide-Acetyl Precursor Solution) and 1(e) and 15(e) (Alkali Catalyst): A key distinction is that US8546449 uses a hydrogen peroxide-acetyl precursor solution followed by an alkali metal or earth alkali metal hydroxide to initiate perhydrolysis. US5122538A uses acetic acid (not an acetyl precursor solution as defined in US8546449) and a sulfonic acid ion-exchange resin as a catalyst, not a strong alkali. Therefore, the specific chemical components and reaction initiation steps are different, making direct anticipation unlikely for these elements.
3. U.S. Patent No. 6,171,551
- Full Citation: US6171551B1, "Method and apparatus for producing aqueous solutions of peracids", Johnson et al., published January 9, 2001.
- Publication/Filing Date: Published January 9, 2001.
- Brief Description: This patent discloses an electrolytic process for producing peracids, including PAA. It employs a cell divided by an ion-exchange membrane where PAA (and other oxidants) are produced in the anode compartment, which consists of an aqueous solution of acetic acid or acetate salt. The patent reports low PAA yields (less than 14 ppm PAA after 90 minutes from a potassium acetate anolyte) and difficulties with intermittent operation.
- Potential Anticipation (35 U.S.C. § 102):
- Claims 1 and 15 (Preamble - Point-of-Use Generation): These claims cover generating non-equilibrium PAA at a point-of-use. US6171551B1 aims to produce PAA on-site using an electrolytic process.
- Claims 1 and 15 (Method Steps): The core methods of US8546449 involve mixing a hydrogen peroxide-acetyl precursor solution with water and then adding a strong alkali. US6171551B1 describes an electrolytic process, which is fundamentally different from the chemical mixing steps claimed in US8546449. The reactants (acetic acid/acetate salt) and the mechanism of PAA formation (electrolysis vs. perhydrolysis catalyzed by strong base) are distinct. Therefore, the specific method steps of claims 1-27 are not anticipated.
4. U.S. Patent No. 6,387,236
- Full Citation: US6387236B1, "Method and apparatus for producing aqueous solutions of peracids", Johnson et al., published May 14, 2002.
- Publication/Filing Date: Published May 14, 2002.
- Brief Description: Similar to US6171551B1, this patent also describes an electrolytic process for producing peracids like PAA using a divided cell with an ion-exchange membrane. It focuses on the use of gas diffusion electrodes for cathodic reduction of oxygen to hydrogen peroxide, which then reacts with acetic acid or an acetyl precursor to form PAA. The system faces challenges with low oxygen solubility, high capital costs, and difficulty in maintaining steady-state conditions due to water movement across the membrane.
- Potential Anticipation (35 U.S.C. § 102):
- Claims 1 and 15 (Preamble - Point-of-Use Generation): As with US6171551B1, this patent discloses on-site generation of PAA.
- Claims 1 and 15 (Method Steps): Again, the method taught by US6387236B1 is an electrolytic process, involving a multi-compartment cell, gas diffusion electrodes, and cathodic reduction, which is distinct from the chemical mixing and alkali-catalyzed perhydrolysis steps of US8546449. The specific ingredients and the order of their introduction (e.g., pre-formed hydrogen peroxide-acetyl precursor solution, then strong alkali) are not present in this electrolytic prior art.
5. U.S. Patent No. 7,012,154
- Full Citation: US7012154B2, "System and method for on-site preparation of peracetic acid", Bunczek et al., published March 14, 2006.
- Publication/Filing Date: Published March 14, 2006.
- Brief Description: This patent describes a system for on-site production of PAA where acetic acid, hydrogen peroxide, water, and sulfuric acid are fed to a jacketed reactor. A wiped-film distillation column isolates pure PAA from the gas phase for immediate introduction to receiving water. The system is noted as capital intensive, involving safety hazards due to pure PAA production, and requiring highly trained technicians.
- Potential Anticipation (35 U.S.C. § 102):
- Claims 1 and 15 (Preamble - Point-of-Use Generation): This patent clearly teaches a "system for on-site preparation of PAA".
- Claims 1 and 15 (Method Steps): The method in US7012154B2 involves reacting acetic acid and hydrogen peroxide with a mineral acid catalyst (sulfuric acid) in a reactor, followed by distillation to isolate pure PAA. This is fundamentally different from the US8546449 claims, which involve a pre-formed hydrogen peroxide-acetyl precursor solution and the use of a strong alkali metal or earth alkali metal hydroxide to drive the perhydrolysis reaction. The absence of a strong alkali and the presence of a distillation step in US7012154B2 differentiate it significantly.
6. U.S. Patent No. 7,651,724
- Full Citation: US7651724B2, "Method and compositions for the determination of peracetic acid", Gilliard et al., published January 26, 2010.
- Publication/Filing Date: Published January 26, 2010.
- Brief Description: This patent describes methods and compositions for the analytical determination (measurement) of peracetic acid, particularly using a modified DPD (N,N-diethyl-p-phenylenediamine) colorimetric method. It relates to quantifying PAA, not to methods or compositions for its generation.
- Potential Anticipation (35 U.S.C. § 102): This patent is directed to an analytical method for PAA, not the generation of PAA. Therefore, it does not anticipate any of the claims of US8546449, which are directed to methods and compositions for generating PAA or solid peroxygen compositions.
7. U.S. Patent Application Publication No. 2007/0082832 A1
- Full Citation: US20070082832A1, "Methods for the production of peracid solutions", Ganske et al., published April 12, 2007.
- Publication/Filing Date: Published April 12, 2007.
- Brief Description: This publication discloses biosynthetic methods for producing peracids, including PAA, from carboxylic acids and carboxylic acid esters. These methods utilize perhydrolase enzymes to catalyze the perhydrolysis of the carboxylic acid or ester into the peracid using a solid or liquid source of hydrogen peroxide. It emphasizes enzyme-catalyzed reactions.
- Potential Anticipation (35 U.S.C. § 102):
- Claims 1 and 15 (Method Steps): The core of US8546449 involves a chemical perhydrolysis reaction catalyzed by a strong alkali. US20070082832A1 relies on enzymatic catalysis for peracid formation. This is a fundamental difference in the reaction mechanism and components. Therefore, the methods of claims 1-27, which do not involve enzymes, are not anticipated.
8. U.S. Patent Application Publication No. 2009/0005590 A1
- Full Citation: US20090005590A1, "Method and apparatus for producing aqueous solutions of peracids", Johnson et al., published January 1, 2009.
- Publication/Filing Date: Published January 1, 2009.
- Brief Description: This publication, similar to US6387236B1, describes an electrolytic process using cation membrane-divided cells and gas diffusion electrodes for the cathodic reduction of oxygen to hydrogen peroxide. The hydrogen peroxide then reacts with acetic acid or an acetyl precursor to form PAA. The catholyte is then directed to the acidic anode compartment to stabilize the PAA.
- Potential Anticipation (35 U.S.C. § 102):
- Claims 1 and 15 (Method Steps): As discussed with previous electrolytic patents (US6171551B1, US6387236B1), the method of US20090005590A1 is electrolytic and involves different components and reaction mechanisms than the alkali-catalyzed perhydrolysis in US8546449. Therefore, the specific method claims 1-27 are not anticipated.
9. U.S. Patent Application Publication No. 2009/0043132 A1
- Full Citation: US20090043132A1, "Methods for generating non-equilibrium peroxyacetic acid solutions", Gilliard et al., published February 12, 2009.
- Publication/Filing Date: Published February 12, 2009.
- Brief Description: This publication discloses a process for generating non-equilibrium PAA solutions on-site by introducing hydrogen peroxide into a sidestream of the water needing treatment, followed by introducing acetic anhydride. PAA is generated in-situ, with acetic anhydride preferentially reacting with hydrogen peroxide over hydrolysis with water. It acknowledges that acetic anhydride is expensive, corrosive, irritant, and highly flammable.
- Potential Anticipation (35 U.S.C. § 102):
- Claims 1 and 15 (Preamble - Point-of-Use Generation): This publication directly addresses "generating non-equilibrium solutions of PAA on site, at the point-of-use".
- Claims 1(b) and 15(b) (Hydrogen Peroxide-Acetyl Precursor Solution): US20090043132A1 uses acetic anhydride as the acetyl precursor. While acetic anhydride is a liquid acetyl precursor, it's introduced separately from hydrogen peroxide, rather than as a pre-formed "hydrogen peroxide-acetyl precursor solution" as defined in US8546449. The specific characteristic of a liquid acetyl precursor that is soluble in aqueous hydrogen peroxide and then forming a pre-solution is a distinguishing feature.
- Claims 1(e) and 15(e) (Alkali Catalyst): Crucially, US20090043132A1 does not disclose the use of an aqueous source of an alkali metal or earth alkali metal hydroxide to initiate the perhydrolysis reaction. Instead, it relies on the reaction between hydrogen peroxide and acetic anhydride directly. This is a key distinguishing feature for claims 1-27 of US8546449.
10. U.S. Patent Application Publication No. 2009/0314652 A1
- Full Citation: US20090314652A1, "Method and apparatus for producing aqueous solutions of peracids", Johnson et al., published December 24, 2009.
- Publication/Filing Date: Published December 24, 2009.
- Brief Description: This publication, similar to other Johnson et al. patents (US6171551B1, US6387236B1, US20090005590A1), describes an electrolytic method for producing peracids. It involves cation membrane-divided electrolysis cells and gas diffusion electrodes to generate hydrogen peroxide from oxygen, which then reacts with acetic acid or an acetyl precursor. The catholyte containing PAA is directed to the acidic anode compartment for stabilization.
- Potential Anticipation (35 U.S.C. § 102):
- Claims 1 and 15 (Method Steps): Similar to the other electrolytic prior art by Johnson et al., this publication describes an electrolytic process, not the chemical mixing and alkali-catalyzed perhydrolysis steps of US8546449. The distinct methodology and chemical components for initiating the reaction mean that the method claims 1-27 are not anticipated.
Summary of Distinctive Features of US8546449 vs. Prior Art:
The key distinguishing features of US8546449's method claims (1-27) when compared to the cited prior art patents for PAA generation are:
- The use of a pre-formed hydrogen peroxide-acetyl precursor solution (e.g., hydrogen peroxide and triacetin solution). Most prior art either reacts H2O2 with acetic acid directly or acetic anhydride separately.
- The subsequent introduction of a highly concentrated aqueous source of an alkali metal or earth alkali metal hydroxide (at least 45% by weight) to drive the perhydrolysis reaction rapidly at the point-of-use. Prior art typically uses acid catalysts, enzymatic catalysts, or electrolytic processes, or does not specify such a concentrated alkali.
- The generation of a non-equilibrium solution of PAA with specific components (PAA, unreacted H2O2, unreacted acetyl precursor, perhydrolysis product, alkali, and water) at non-equilibrium concentrations.
For the solid composition claims (28-40), the distinctiveness lies in:
- A freely-flowable, solid peroxygen bleaching and stain removal composition comprising a liquid acetyl precursor (preferably triacetin), a water-soluble solid source of hydrogen peroxide, and a water-soluble solid source of alkalinity. Prior art, such as TAED-containing bleaches, suffered from low water solubility of the acetyl precursor and undesirable odors upon storage. The use of a liquid acetyl precursor within a solid composition is a key differentiator.
Based on this analysis, while some prior art generally teaches on-site PAA generation, none appear to fully anticipate all elements of US8546449's claims, particularly the specific combination of a pre-mixed hydrogen peroxide-acetyl precursor solution and the use of a concentrated strong alkali, or the specific solid composition with a liquid acetyl precursor.
Generated 5/23/2026, 6:48:29 PM
Obviousness
Combinations of prior art that suggest the claimed invention would have been obvious under 35 U.S.C. § 103.
Obviousness Analysis of US Patent 8546449 Under 35 U.S.C. § 103
This analysis assesses the obviousness of the independent claims of US Patent 8546449, specifically Claims 1, 14, 15, and 16, under 35 U.S.C. § 103, based on the provided prior art. For a patent claim to be obvious, it must be shown that a person having ordinary skill in the art (PHOSITA) would have been motivated to combine existing prior art references and would have had a reasonable expectation of success in achieving the claimed invention at the time of the invention (i.e., prior to the March 24, 2011, priority date).
Claims 1, 14, and 15: Methods and Compositions for Liquid On-Site Peracetic Acid Generation
Claims 1 and 14 describe methods for continuously or intermittently generating non-equilibrium peracetic acid (PAA) solutions on-site at the point-of-use, either in flowing water or a container of water, respectively. Claim 15 describes the preparation of the hydrogen peroxide-acetyl precursor solution used in these methods. The core differentiating features of these claims involve:
- Using a pre-formed "hydrogen peroxide-acetyl precursor solution" where the acetyl precursor is triacetin (Claim 15).
- Introducing this solution to water, followed by or simultaneously with, a highly concentrated aqueous source of an alkali metal or earth alkali metal hydroxide (at least 45% by weight) to achieve specific pH and conversion rates for rapid PAA generation (Claims 1, 14).
Combination of Prior Art: US20090043132A1 (Gilliard et al.) in view of general chemical knowledge regarding perhydrolysis, the properties of various acetyl precursors, and the drawbacks of prior art methods.
Analysis:
- Starting Point: US20090043132A1 (Gilliard et al.) directly teaches a method for "generating non-equilibrium solutions of PAA on site, at the point-of-use" by introducing hydrogen peroxide and acetic anhydride into water. This reference establishes the goal of on-site, non-equilibrium PAA generation from hydrogen peroxide and an acetylating agent.
- Motivation to Substitute Acetyl Precursor: The patent US8546449 itself, in its background, acknowledges the significant drawbacks of using acetic anhydride, stating it is "expensive, very corrosive, an irritant, and highly flammable." [cite: "All processes that employ acetic anhydride suffer the limitation that acetic anhydride is expensive, very corrosive, an irritant, and highly flammable."] A PHOSITA, faced with these known disadvantages, would be strongly motivated to find a safer, less hazardous, and more user-friendly liquid acetyl precursor for on-site PAA generation. Triacetin is a known liquid acetyl precursor for peracid generation (as evidenced by its discussion in US8546449's background in relation to laundry bleaching, implying its general knowledge in the field) and is less hazardous than acetic anhydride. The patent also notes that triacetin exhibits "an unexpectedly high solubility in hydrogen peroxide," further supporting its suitability as a replacement. [cite: "a preferable acetyl precursor is triacetin, which displays an unexpectedly high solubility in hydrogen peroxide."]
- Motivation to Introduce a Strong Alkali Catalyst: While US20090043132A1 relies on the direct reaction between hydrogen peroxide and acetic anhydride, general chemical principles teach that perhydrolysis reactions are significantly accelerated under alkaline conditions due to the increased concentration of the perhydroxyl anion (HO₂⁻). [cite: "the perhydroxyl anion (HO₂−) then affects nucleophilic substitution reactions on the carbonyl groups of the acetyl precursor in a perhydrolysis reaction to form peracetic acid and the product of the perhydroloysis reaction of the acetyl precursor."] Prior art, such as US3432546A (Hohn et al.), also demonstrates the use of an alkali (ammonium hydroxide) as a catalyst for PAA production. However, the background of US8546449 explicitly identifies ammonium hydroxide as an "undesirable contaminant" for PAA products used as disinfectants and sanitizers in food and beverage industries. [cite: "Ammonium hydroxide is an undesirable contaminant in PAA products that are used as disinfectants and sanitizers in the dairy, food, and beverage processing industries, and in PAA products used in fruit and vegetable washing and in the treatment of meat, poultry, and seafood."] Therefore, a PHOSITA, seeking to overcome the limitations of acetic anhydride and undesirable catalysts, while aiming for rapid and efficient PAA generation from triacetin on-site, would be motivated to introduce a strong, food-acceptable alkali. Alkali metal hydroxides, such as sodium hydroxide (NaOH) or potassium hydroxide (KOH), are well-known, readily available, and strong bases commonly used in industrial chemical processes and for pH adjustment. The use of a highly concentrated aqueous solution of these hydroxides (e.g., "at least 45% by weight" as claimed) would be a logical choice for a PHOSITA to rapidly and effectively drive the perhydrolysis reaction and achieve high PAA conversion, with the specific concentrations and pH ranges being matters of routine experimentation and optimization.
- Motivation for Pre-formed Solution (Claim 15): Given triacetin's high solubility in aqueous hydrogen peroxide, as highlighted by the patent itself, forming a pre-mixed "hydrogen peroxide-triacetin solution" (as described in Claim 15) would be an obvious engineering and formulation step for a PHOSITA. [cite: "a preferable acetyl precursor is triacetin, which displays an unexpectedly high solubility in hydrogen peroxide."] This would simplify the logistics of on-site delivery and accurate metering of the two reactants, and ensure efficient initial mixing before the addition of the alkali, thereby streamlining the overall PAA generation process, which addresses common industrial challenges (e.g., accurately metering multiple liquids simultaneously).
- Reasonable Expectation of Success: The perhydrolysis reaction of an acetyl precursor with hydrogen peroxide under alkaline conditions is a well-understood chemical process. A PHOSITA would have a reasonable expectation of success in achieving rapid PAA generation by optimizing the known alkaline perhydrolysis reaction using a soluble acetyl precursor like triacetin and a concentrated strong alkali. The specific ranges for reactant ratios, concentrations, and resulting PAA levels claimed would be derivable through routine optimization experiments by a PHOSITA.
Therefore, Claims 1, 14, and 15 would likely be rendered obvious by the combination of US20090043132A1 with general chemical knowledge of perhydrolysis, the known properties of triacetin as an acetyl precursor, and the motivation to improve upon the hazards and inefficiencies of prior art methods.
Claim 16: Solid Peroxygen Bleaching and Stain Removal Composition
Claim 16 defines a freely-flowable, solid peroxygen bleaching and stain removal composition comprising a liquid acetyl precursor (triacetin), a water-soluble solid source of hydrogen peroxide (sodium percarbonate), and a water-soluble solid source of alkalinity, with specific percentage ranges.
Combination of Prior Art: General knowledge of solid laundry bleach formulations (e.g., those implicitly or explicitly using solid hydrogen peroxide sources and acetyl precursors like TAED, and alkalinity sources) in view of the patent's own background discussing deficiencies of such formulations, and general chemical knowledge regarding alternative acetyl precursors.
Analysis:
- Starting Point: The background section of US8546449 itself clearly describes existing laundry bleaching applications where PAA is generated in-situ in the wash water. It explicitly states: "The PAA is typically produced from a solid source of hydrogen peroxide, such as sodium percarbonate or sodium perborate. The hydrogen peroxide must be in the presence of a solid acetyl precursor, most typically, tetraacetylethylenediamine (TAED)." [cite: "PAA is also used in laundry bleaching applications where it is generated in-situ in the laundry wash water.", "the PAA is typically produced from a solid source of hydrogen peroxide, such as sodium percarbonate or sodium perborate.", "the hydrogen peroxide must be in the presence of a solid acetyl precursor, most typically, tetraacetylethylenediamine (TAED)."] These formulations inherently require an alkalinity source to facilitate the perhydrolysis reaction, which can be provided by the percarbonate itself or by additional builders, as is common in bleach compositions.
- Motivation to Modify: The patent goes on to highlight significant problems with TAED in these solid bleach formulations: "TAED has low water solubility, especially at the cooler water temperature bleaching cycles that are less damaging to fabrics. This is a major drawback... Undissolved TAED in cool temperature water is less unavailable as an acetyl precursor for the dissolved source of hydrogen peroxide and can even deposit on fabrics, necessitating a separate rinse step to remove it." [cite: "TAED has low water solubility, especially at the cooler water temperature bleaching cycles that are less damaging to fabrics.", "Undissolved TAED in cool temperature water is less unavailable as an acetyl precursor for the dissolved source of hydrogen peroxide and can even deposit on fabrics, necessitating a separate rinse step to remove it."] The patent concludes that "Thus, there is a need for a solid, peroxygen bleach that overcomes the deficiencies of the TAED-containing bleaches." [cite: "Thus, there is a need for a solid, peroxygen bleach that overcomes the deficiencies of the TAED-containing bleaches."] A PHOSITA in the field of laundry bleach formulation would be strongly motivated to address these clearly identified deficiencies.
- Substitution with Triacetin: Triacetin is a known liquid acetyl precursor with excellent water solubility. Substituting the problematic solid TAED with a more soluble liquid acetyl precursor like triacetin in a solid bleach formulation would be an obvious design choice for a PHOSITA aiming to improve cold-water performance and prevent fabric deposition. The maintenance of the solid hydrogen peroxide source (e.g., sodium percarbonate, explicitly mentioned in the background) and a solid alkalinity source (common in bleaches and essential for perhydrolysis) would also be obvious.
- Achieving "Freely-Flowable Solid": Incorporating a liquid component (triacetin) into a solid mixture while maintaining a "freely-flowable" characteristic is a routine formulation challenge in chemistry. The patent itself demonstrates that "the triacetin could be blended with up to 8.45 g of the triacetin to form a freely-flowable solid composition, without becoming a sticky, non-flowable product which would not pour easily or would become a solid mass upon storage inside a container." [cite: "the triacetin could be blended with up to 8.45 g of the triacetin to form a freely-flowable solid composition, without becoming a sticky, non-flowable product which would not pour easily or would become a solid mass upon storage inside a container."] This indicates that achieving such a physical form is a solvable problem through routine formulation techniques and optimization of component ratios, which would be predictable to a PHOSITA. The selection of various water-soluble solid alkalinity sources (bicarbonate, carbonate, etc.) and their specific ranges would also fall within the ambit of routine experimentation for bleach formulations.
- Reasonable Expectation of Success: The underlying chemical reaction (perhydrolysis to form PAA) is well-understood. A PHOSITA would have a reasonable expectation that replacing a poorly soluble acetyl precursor with a highly soluble one, while maintaining the other necessary components (H2O2 source, alkalinity), would lead to improved PAA generation in solution, particularly in cold water, thus overcoming the known drawbacks. The specific composition ranges claimed would be derivable through routine optimization.
Therefore, Claim 16 would likely be rendered obvious by combining the known elements of solid laundry bleach formulations (as described in the patent's own background) with the recognized properties of triacetin as a soluble acetyl donor, motivated by the clearly stated need to overcome the deficiencies of TAED-based bleaches.
Generated 5/24/2026, 12:46:33 AM
Extensions
Patent term adjustments, term extensions, continuations, divisionals, family members, and expiration dates.
For US Patent 8546449, here's a detailed breakdown of its patent term adjustments, extensions, continuation applications, divisional applications, related family members, and projected expiration date:
Patent Term Adjustments (PTA) and Extensions (PTE)
- Patent Term Adjustments (PTA): US Patent 8546449 has an "Adjusted expiration" date of 2031-09-02. PTA is granted to compensate for delays by the USPTO during the prosecution of a patent application. The total PTA adds to the 20-year lifespan of the issued patent.
- Patent Term Extensions (PTE): There is no indication of Patent Term Extension (PTE) for US8546449 in the provided information. PTE is typically awarded to compensate for delays in obtaining regulatory approval for certain patented products, such as pharmaceuticals.
Continuation and Divisional Applications
US Patent 8546449 (which issued from application US13/065,553 filed on March 24, 2011) is part of a patent family that includes continuation-in-part and divisional applications.
Continuation Applications:
- US10912321B2 (US Patent No. 10,912,321): This patent, titled "Methods of using peracetic acid to treat poultry in a chill tank during processing," is a continuation-in-part of and claims priority to the application (US13/065,553) that led to US8546449. It was filed on August 16, 2011, and issued on February 9, 2021.
Divisional Applications:
The litigation record for IPR2025-01472 explicitly mentions that the district court case against Clean Chemistry, Inc. alleges infringement of US8546449, as well as three divisional patents:
- US9737072 (U.S. Patent No. 9,737,072): This is identified as a divisional patent of US8546449. Its priority date is March 7, 2016.
- US9730443 (U.S. Patent No. 9,730,443): This is identified as a divisional patent of US8546449. Its priority date is March 7, 2016.
- US9363997 (U.S. Patent No. 9,363,997): This is identified as a divisional patent of US8546449. Its priority date is April 8, 2015.
Related Family Members
In addition to the continuation-in-part and divisional applications mentioned above, other related patent family members include:
- US20120245228A1: This is a publication of the application that led to US8546449, published on September 27, 2012.
- US9370180B2 (U.S. Patent No. 9,370,180): This patent, titled "Methods and compositions for the generation of peracetic acid on site at the point-of-use," was filed on September 5, 2013, and issued on June 21, 2016. It is broadly related and shares the same title.
- US10004230B2 (U.S. Patent No. 10,004,230): This patent is also listed as one of the patents issued subsequently to US8546449 within Enviro Tech's portfolio.
- US20170311595A1: This application, titled "Methods and Compositions for the Generation of Peracetic Acid On Site at the Point-of-Use," was filed on July 18, 2017, and published on November 2, 2017.
Projected Expiration Date
The "Adjusted expiration" date for US8546449 is 2031-09-02. This date includes any Patent Term Adjustment (PTA) granted to the patent. Utility patents generally have a term of 20 years from their earliest filing date, which can be extended by PTA for USPTO administrative delays. The original filing date for the application that led to US8546449 was March 24, 2011.
Generated 5/28/2026, 3:37:08 AM
Derivative works
Defensive disclosure: derivative variations of each claim designed to render future incremental improvements obvious or non-novel.
USPTO Search Confirmation
Before drafting, I verified the target patent identity per the strict-ID rule. Searches for 8546449 (no auto-correction) return US8546449B2, "Methods and compositions for the generation of peracetic acid on site at the point-of-use," inventors Michael S. Harvey and Jonathan N. Howarth, assignee Enviro Tech Chemical Services, Inc., priority 2011-03-24, granted 2013-10-01. Sources: Google Patents (patents.google.com/patent/US8546449), PubChem patent record US-8546449-B2, Justia (patents.justia.com/patent/9363997 citing the '449 family), and the PTAB record IPR2025-01459 (Exhibit 1007 = US Patent No 8546449). No similar-number confusion was observed. Note: I accessed USPTO-ecosystem mirrors (Google Patents, PubChem, PTAB filings) rather than the raw USPTO full-text server; the substantive text matches the authoritative copy provided in the task, which controls on conflict.
DEFENSIVE DISCLOSURE — US 8546449B2 DERIVATIVE VARIATION SET
Docket: ETCS-DD-2026-001 · Filed (intent): April 26, 2026 · Discloser role: Defensive publication to establish prior art under 35 U.S.C. § 102(a)(1) and § 102(a)(2) for incremental improvements over US 8546449B2.
Scope of this disclosure: This document does not restate the claims of US 8546449B2. It discloses new, non-claimed derivative embodiments — compositions, apparatus, control logic, and methods — that a person having ordinary skill in the art (PHOSITA) could practice without inventive step, once this disclosure is published. Each derivative is keyed to one of the four independent claim groups of US 8546449B2 (Claim 1 — flowing-stream generation; Claim 14 — vessel/batch generation; Claim 15 — precursor solution preparation; Claim 16 — solid peroxygen composition) and is mapped to one of five derivation axes: (A) Material & Component Substitution, (B) Operational Parameter Expansion, (C) Cross-Domain Application, (D) Integration with Emerging Technology, (E) Inverse / Failure-Mode Design. Every derivative includes an enabling description and a machine-renderable Mermaid.js diagram.
GROUP 1 — DERIVATIVES OF CLAIM 1 (FLOWING-WATER CONTINUOUS/INTERMITTENT PAA GENERATION)
D1.1 — Axis A: Substituted acetyl precursors and mixed-alkali activation
Enabling Description. Replace triacetin, in whole or in part, with a homologous liquid polyol acetate that is soluble in 50% aqueous hydrogen peroxide at ≥20 wt% at 25 °C: diacetin (glycerol diacetate, mixture of 1,2- and 1,3-diacetates), propylene glycol diacetate (PGDA), ethylene glycol diacetate (EGDA), or glyceryl tributyrate (for propionyl/perbutyryl peracid generation). Substitute 50% NaOH with 45% KOH, 50% KOH, or a 9:1 to 1:9 w/w NaOH/KOH blend, optionally with 1–5 wt% LiOH·H2O as a reaction-rate promoter. The mole ratio of hydroxide:hydrogen peroxide:acetyl-precursor is held within 4.2:3.8:1 to 4:4:1 by a two-pump ratio controller. When PGDA (2 acetyl groups) is used, stoichiometric H2O2 demand is 2 mol per mol PGDA; the claimed triacetin conversion figures (40.9–85.7%) are renormalized to per-acetyl-group conversion (≥60% of available acetyl groups). The perhydrolysis product is propylene glycol (for PGDA) instead of glycerine. All other process parameters (5.6–22.5 wt% precursor solution in the stream, pH 11.2–13.37, 30 s–5 min residence) remain as in the base claim.
graph TD
A[Raw water inlet] --> B[Pressure regulator]
B --> C[Flow meter]
C --> D[Static mixer]
E[Precursor drum: H2O2 + PGDA/diacetin] --> F[Pump P1]
F --> D
G[KOH/NaOH blend drum] --> H[Pump P2]
H --> I[Injection quill]
D --> I
I --> J[Residence chamber 30s]
J --> K[Residence chamber 5min]
K --> L[Sampling port]
L --> M[PAA product to point-of-use]
N[Ratio controller] --> F
N --> H
N --> C
D1.2 — Axis B: Microfluidic and milli-fluidic extreme-scale operation
Enabling Description. Operate the same chemistry in a continuous microfluidic reactor at 10–1000 μL/min total flow. The water stream (deionized, 0.1–1.0 mL/min) is combined with the H2O2–triacetin precursor solution (5.6–22.5 wt% of total) in a staggered herringbone passive micromixer (channel depth 50–200 μm, hydraulic diameter 100–400 μm), then with 45–50% NaOH via a third inlet at a mole ratio of 4.2:3.8:1 to 4:4:1 (NaOH:H2O2:triacetin). Reaction proceeds in a serpentine residence channel sized for 30 s at the design flow. Because diffusional mixing in the 100–400 μm regime is complete in <1 s, PAA generation reaches its maximum (1–7.1% PAA in the effluent) within the serpentine channel without any static-mixer packing. pH is monitored inline with an ISFET micro pH probe (11.2–13.37). Conversely, at industrial scale (0.1–10 m³/min), the same ratios are preserved using an annular multi-tube static mixer bank with 19–37 parallel tubes to keep the Reynolds number >4000 in each tube.
flowchart LR
S1[Syringe pump: water] --> M1[Herringbone micromixer]
S2[Syringe pump: H2O2-triacetin] --> M1
M1 --> M2[NaOH inlet tee]
S3[Syringe pump: 50% NaOH] --> M2
M2 --> R[Serpentine channel 30s]
R --> ISFET[pH ISFET probe]
ISFET --> P[PAA effluent 1-7.1%]
ISFET --> C[Controller feedback to S3]
D1.3 — Axis C: Aerospace closed-loop water disinfection
Enabling Description. Apply the flowing-stream method to spacecraft potable-water and humidity-condensate loops (e.g., Environmental Control and Life Support System analog). Water at 0.5–4 L/min in a ½″ Ti-6Al-4V or PEEK line is dosed with a pre-mixed H2O2–triacetin solution (5.6–22.5 wt% of total) and then with 45% KOH (preferred over NaOH in microgravity to reduce sodium-loading on the water-recovery processor). The mole ratio KOH:H2O2:triacetin is 4.2:3.8:1 to 4:4:1. Residence is provided by a coiled 6 m × 6.35 mm O.D. tube (30 s at 1 L/min). The product stream (1–7.1% PAA) is injected into the potable-water bus at a dose of 1–10 ppm PAA, achieving disinfection without the storage hazards of equilibrium PAA (no >6% PAA shipped; no DOT 5.2 label). Residual PAA is catalytically decomposed by a MnO2-coated mesh before crew consumption. Glycerine (perhydrolysis by-product) is recovered by the condensate processor. All wetted materials (PEEK, EPDM, Ti) are PAA-compatible.
flowchart TD
A[Cabin humidity condensate] --> B[Particulate filter]
B --> C[Flow meter 0.5-4 L/min]
C --> D[Mixing tee 1]
E[Bag: H2O2-triacetin precursor] --> F[Peristaltic pump P1]
F --> D
D --> G[Mixing tee 2]
H[Bag: 45% KOH] --> I[Peristaltic pump P2]
I --> G
G --> J[Coiled residence tube 30s]
J --> K[PAA dosing point 1-10 ppm]
K --> L[MnO2 decomposition bed]
L --> M[Potable water bus]
D1.4 — Axis D: AI-optimized, IoT-instrumented, blockchain-verified dosing
Enabling Description. Instrument the flowing-stream apparatus with: (i) a Coriolis flow meter on the water line; (ii) an ORP electrode and a pH electrode downstream of the residence chambers; (iii) a UV-Vis absorbance cell at 525 nm using the DPD chemistry of US 7,651,724 (or the equivalent EPA 330.5 method) for PAA quantification; and (iv) peristaltic pumps with encoder feedback. A programmable logic controller executes a model-predictive control loop: a neural-network surrogate model (trained offline on 2,000+ batch kinetic runs) predicts the PAA concentration 60 s ahead and adjusts the NaOH pump to hold the reaction medium at pH 12.0 ± 0.3 while minimizing NaOH consumption (target: ≥80% triacetin acetyl-group conversion). IoT telemetry (MQTT, 5 s cadence) publishes flow, pH, ORP, PAA ppm, and pump stroke counts to a cloud historian. Each 1,000-L production lot of precursor solution is registered on an immutable ledger (private Ethereum or Hyperledger Fabric channel) with a SHA-256 hash of the certificate-of-analysis; the dosing controller verifies the ledger entry before enabling the NaOH pump, providing supply-chain provenance (triacetin source, H2O2 lot, stabilizer content) at the point of use.
sequenceDiagram
participant FM as Coriolis flow meter
participant PLC as PLC/Edge AI
participant P1 as H2O2-triacetin pump
participant P2 as NaOH pump
participant S as Sensors (pH/ORP/UV-Vis)
participant C as Cloud historian
participant B as Blockchain ledger
FM->>PLC: flow rate (4-20 mA)
PLC->>P1: setpoint (precursor dose)
PLC->>P2: setpoint (NaOH ratio)
P1->>S: precursor into stream
P2->>S: NaOH into stream
S->>PLC: pH, ORP, PAA ppm
PLC->>PLC: NN surrogate prediction (60 s horizon)
PLC->>P2: trim NaOH setpoint
PLC->>C: MQTT telemetry (5 s)
PLC->>B: verify lot hash (pre-enable)
B-->>PLC: verified
D1.5 — Axis E: Passive, pump-free, fail-safe "limited-functionality" doser
Enabling Description. Disclose a gravity-fed, pump-free variant for intermittent duty in low-resource settings. A 20-L HDPE head tank contains the H2O2–triacetin precursor solution; a second 5-L tank contains 50% NaOH. Flow is driven solely by hydrostatic head (0.5–2 m) through fixed orifice restrictors (0.3–0.8 mm ID sapphire or ruby orifices) sized so that the precursor solution is 5.6–22.5 wt% of the water stream and the NaOH:H2O2:triacetin mole ratio is 4.2:3.8:1 to 4:4:1 at the design water flow of 5–20 L/min. A float-actuated shutoff valve stops both feeds if the receiving water flow drops below 60% of design (fail-safe: no concentrated alkali discharge). If the NaOH tank empties first, a spring-loaded check valve admits atmospheric air into the NaOH line, breaking siphon and stopping the precursor feed (interlock). Maximum achievable PAA is capped at 1% by a dilution weir, so the device cannot produce a DOT 5.2 hazardous stream. This is the "limited-functionality" inverse: it sacrifices conversion optimization (triacetin conversion 40–60%) for inherent safety and zero-electricity operation.
stateDiagram-v2
[*] --> Ready
Ready --> Dosing: water flow > 60% design
Dosing --> Dosing: gravity feed precursor + NaOH
Dosing --> SafeStop: water flow < 60%
Dosing --> SafeStop: NaOH tank empty
SafeStop --> Ready: operator resets and refills
SafeStop --> [*]: end of shift
GROUP 2 — DERIVATIVES OF CLAIM 14 (VESSEL/BATCH GENERATION)
D14.1 — Axis A: Eductor-mixed vessel with alternative alkalinity package
Enabling Description. Replace the overhead agitator with a tank-bottom eductor (venturi) recirculation loop: a 1–10 m³ HDPE or 316L vessel is recirculated at 3–10 vessel-volumes/hour by a centrifugal pump through a 2″ eductor, entraining the H2O2–triacetin precursor solution and the alkali through two suction ports. The alkali is delivered as a 45–50% KOH solution, or as a slurry of sodium carbonate/sodium metasilicate (30 wt% solids) where a delayed pH ramp (pH 10.5→12.5 over 60 s) is desired. Water hardness is preconditioned by a cation-exchange softener or by dosing 0.1–1 g/L sodium hexametaphosphate (SHMP) as a calcium-sequestrant, preserving the "no calcium-salt precipitation" requirement. The mole ratio alkali:H2O2:triacetin is 4.2:3.8:1 to 4:4:1; PAA reaches 1–7.1% within 5 min at 15–25 °C. The eductor eliminates shaft seals and enables CIP of the vessel with the same PAA solution.
graph TD
A[Vessel 1-10 m3 softened water] --> B[Centrifugal recirc pump]
B --> C[Eductor]
C --> A
D[Precursor drum H2O2-triacetin] --> E[Suction port 1]
E --> C
F[KOH or carbonate/silicate slurry] --> G[Suction port 2]
G --> C
C --> H[Reaction medium pH 11.2-13.37]
H --> I[Sampling valve]
I --> J[PAA 1-7.1% in vessel]
D14.2 — Axis B: Cryogenic and high-thermal-mass batch extremes
Enabling Description. Expand the batch method to two thermal extremes. (i) Cold-chain / chilled operation: soften water to <50 ppm hardness, chill to 1–8 °C, and dose precursor and 50% NaOH at the 4.2:3.8:1 to 4:4:1 mole ratio; because the perhydrolysis activation energy is modest, PAA generation is slowed to a 10–20 min maximum window, which is useful for preparing "antimicrobial ice" or chilled poultry-chill-tank water at 1–4 °C. (ii) Thermally massive industrial batch: in a 50 m³ concrete or fiberglass tank (e.g., vegetable flume water), the exotherm (≈15–25 kJ/mol per acetyl group) is absorbed by the thermal mass; peak temperature rise is <3 °C. The same mole ratios and pH window apply. The disclosure specifically claims the ranges 1–8 °C and 25–45 °C with residence extended to 20 min for the cold case.
flowchart LR
A[Chilled soft water 1-8C] --> B[Batch vessel 50 m3]
C[Precursor H2O2-triacetin] --> B
D[50% NaOH] --> B
B --> E[Slow perhydrolysis 10-20 min]
E --> F[PAA 1-7.1% at 4C]
F --> G[Chill tank / antimicrobial ice]
D14.3 — Axis C: Aquaculture and hydroponics batch sanitation
Enabling Description. Apply the vessel method to live-animal transport and soilless-culture systems. (i) Aquaculture transport: in a 1–5 m³ fish-transport tank with recirculating water at 10–18 °C, dose H2O2–triacetin precursor (to 5.6–22.5 wt% of the tank charge) and 50% NaOH at a 4:4:1 mole ratio to generate 1–7.1% PAA in a sidestream, then inject the PAA sidestream into the tank at 1–5 ppm to control saprolegniasis and bacterial gill disease without accumulating equilibrium PAA storage hazards; the alkaline PAA stream is neutralized by the fish metabolic CO2 load. (ii) Hydroponics: in a 500–2,000 L nutrient reservoir, the same chemistry generates PAA for root-zone disinfection (Pythium control) at 2–10 ppm, with glycerine by-product serving as a benign carbon source; softened or RO water is used to prevent calcium phosphate/PAA-salt precipitation.
graph TD
A[Transport tank / nutrient reservoir] --> B[Sidestream pump]
B --> C[Mixer]
D[Precursor H2O2-triacetin] --> C
E[50% NaOH] --> C
C --> F[PAA sidestream 1-7.1%]
F --> G[Injection to tank 1-10 ppm]
G --> A
D14.4 — Axis D: IoT-adaptive batch controller with ORP/pH cascade
Enabling Description. Equip the batch vessel with a pH electrode, ORP electrode, temperature probe, and a guided-wave radar level transmitter. A cascaded control scheme operates as follows: the outer loop holds pH at 12.0 ± 0.2 by trimming the 50% NaOH dose; the inner loop holds PAA (inferred from ORP via a calibration curve, verified by periodic DPD grab samples) at a user-set target of 0.5–5% by trimming the precursor dose. A machine-learning classifier (gradient-boosted trees) detects water-hardness excursions from the pH/ORP response shape and recommends softening regeneration. All events (dose, pH, PAA, lot hash) are logged to a blockchain-anchored quality record satisfying FDA 21 CFR Part 11 audit-trail expectations for food-contact sanitizer preparation. The controller supports both continuous and intermittent (shift-based) operation and automatically executes a safe-hold (both pumps off) if pH exceeds 13.4 or vessel level falls below the pump suction cutoff.
graph TD
subgraph Field
PH[pH probe]
ORP[ORP probe]
T[Temp probe]
L[Level radar]
end
subgraph Control
PLC[PLC cascade]
ML[Gradient-boosted hardness classifier]
end
subgraph Actuation
P1[Precursor pump]
P2[NaOH pump]
end
PH --> PLC
ORP --> PLC
T --> PLC
L --> PLC
PLC --> P1
PLC --> P2
PLC --> ML
ML --> PLC
PLC --> B[Blockchain quality record]
D14.5 — Axis E: Unit-dose fail-safe batch sachet (limited-functionality mode)
Enabling Description. Disclose a single-use, pre-weighed, water-soluble film sachet (PVOH, e.g., 40 μm cold-water-soluble grade) containing two segregated compartments: compartment A holds 20–80 g of the H2O2–triacetin precursor solution (immobilized on a silica aerogel or superabsorbent polymer to prevent rupture), and compartment B holds 15–60 g of anhydrous sodium carbonate/sodium percarbonate blend (solid alkalinity + supplemental H2O2). The user drops the sachet into a 20–100 L bucket of softened water. The PVOH dissolves in 2–5 min; the delayed release of compartment B (coated with a 5 μm ethylcellulose barrier) raises pH from ~7 to 11.5–12.5 over 10 min, generating 0.1–1% PAA — deliberately below the 1% PAA minimum of the parent claim, so the device is a "limited-functionality" fail-safe that cannot produce a hazardous concentration and cannot be accidentally over-dosed. The sachet is inherently single-use (no metering error), and any unreacted NaOH is neutralized by the carbonates.
stateDiagram-v2
[*] --> Dry: sachet stored
Dry --> Wetting: added to 20-100L water
Wetting --> PrecursorRelease: PVOH dissolves 2-5 min
PrecursorRelease --> AlkaliDelay: ethylcellulose barrier 5 um
AlkaliDelay --> Reaction: pH 11.5-12.5
Reaction --> Product: 0.1-1% PAA max
Product --> [*]: single-use, spent film dissolves
GROUP 3 — DERIVATIVES OF CLAIM 15 (PRECURSOR SOLUTION PREPARATION)
D15.1 — Axis A: Stabilizer-system and co-solvent substitution
Enabling Description. The base precursor solution (23–40% H2O2 from 50% aqueous H2O2, 20–52% triacetin, water, trace PAA) is modified by substituting the incidental acidity control with explicit, FDA-listed stabilizers at low dose: 10–500 ppm dipicolinic acid, 10–500 ppm HEDP, or 50–1,000 ppm of a phosphonate-free stabilizer package (sodium stannate 50–200 ppm + sodium pyrophosphate 50–200 ppm + 8-hydroxyquinoline 5–50 ppm) to suppress transition-metal decomposition. A co-solvent (propylene glycol, glycerol, or ethanol, 0.5–5 wt%) is optionally added to lower the pour point of the precursor to −15 °C and to adjust the viscosity to 5–20 cP for pump accuracy. The mole ratio H2O2:triacetin remains 2.98:1 to 12.84:1, and the solution retains the property of forming trace PAA within the first day (0.004–1.3% PAA at day 1) while the H2O2 fraction remains ≥90% of initial after 30 days at 30 °C.
classDiagram
class PrecursorSolution {
+float h2o2_pct = 23..40
+float triacetin_pct = 20..52
+float water_balance
+float paa_trace_day1 = 0.004..1.3
+float stabilizer_ppm = 10..1000
+float cosolvent_pct = 0.5..5
+float mole_ratio_h2o2_triacetin = 2.98..12.84
+mix()
+verify_stability_30d()
}
class Stabilizer {
+type: dipicolinic acid | HEDP | stannate+pyrophosphate
+dose_ppm
}
class CoSolvent {
+type: propylene glycol | glycerol | ethanol
+pour_point_C
}
PrecursorSolution --> Stabilizer
PrecursorSolution --> CoSolvent
D15.2 — Axis B: High-strength and cold-chain precursor extremes
Enabling Description. Disclose a high-strength precursor: mix 70% aqueous H2O2 (not 50%) with triacetin to achieve 40–52% H2O2 and 25–40% triacetin (H2O2:triacetin mole ratio 2.98:1 to 12.84:1), with water balance as low as 8%. Because >27% H2O2 solutions are exempt from the DOT 5.2 Organic Peroxide label (as recognized in the parent patent), this precursor ships as a Class 5.1 oxidizer only. Cold-chain variant: the precursor is formulated and stored at −20 °C to +4 °C in HDPE totes; at −20 °C the solution remains liquid (freezing point suppressed by the triacetin and H2O2 eutectic to below −25 °C), enabling year-round outdoor storage in northern climates. A phase-stability requirement is disclosed: no crystallization or phase separation after 10 freeze-thaw cycles (−20 °C ↔ +25 °C), verified by visual inspection and by H2O2 titration (ceric sulfate-iodometric method).
flowchart LR
A[70% H2O2] --> B[Blending tank jacketed -20 to +4C]
C[Triacetin] --> B
B --> D[High-strength precursor 40-52% H2O2]
D --> E[Freeze-thaw test x10]
E --> F{Phase stable?}
F -->|yes| G[Ship as Class 5.1 oxidizer]
F -->|no| H[Re-formulate cosolvent]
D15.3 — Axis C: Oil & gas, pulp & paper, and marine ballast applications
Enabling Description. (i) Oil & gas: prepare the precursor solution at a blending skid adjacent to a fracturing or produced-water station; inject the precursor plus 45% KOH into a sidestream of the water to be treated at the 4.2:3.8:1 to 4:4:1 mole ratio to generate 1–7.1% PAA for sulfide-oxidation and biofilm control in frac water and sulfate-reducing bacteria (SRB) control in produced-water reinjection. (ii) Pulp & paper: use the precursor to generate PAA for slime control in white-water loops; the alkaline pH and glycerine by-product are compatible with alkaline papermaking conditions. (iii) Marine ballast: generate PAA in ballast-water sidestreams during uptake to meet IMO D-2 ballast-water performance standards for indicator microbes (E. coli < 250 CFU/100 mL; Enterococci < 100 CFU/100 mL), using seawater (which is naturally buffered) with a reduced NaOH dose to hold pH ≤ 12.
graph TD
P[Precursor blending skid] --> A[Oil & gas: frac water sidestream]
P --> B[Pulp & paper: white-water loop]
P --> C[Marine: ballast water uptake]
A --> A1[SRB/biofilm control]
B --> B1[Slime control]
C --> C1[IMO D-2 compliance]
D15.4 — Axis D: Inline continuous blending with blockchain lot provenance
Enabling Description. Replace batch blending with continuous inline blending: 50% H2O2 and triacetin are metered by two Coriolis mass-flow meters into a Kenics-type static mixer at 5–50 L/min, with an inline density cell and refractometer verifying composition (target density 1.15–1.25 g/mL; refractive index 1.38–1.42 at 20 °C). The blended precursor passes through a 10-μm bag filter into totes. Every 1,000-L lot is auto-sampled, and the certificate of analysis (H2O2 by ceric sulfate titration, PAA by DPD per US 7,651,724 or EPA 330.5, specific gravity, pH) is hashed onto a blockchain (Hyperledger Fabric or Ethereum) with a GS1 Digital Link QR code on the tote. Downstream dosing controllers (per D1.4) read the QR, verify the hash, and only then enable the alkali pump — closing the loop between precursor provenance and PAA generation.
flowchart TD
A[50% H2O2 bulk] --> C1[Coriolis MFM 1]
B[Triacetin bulk] --> C2[Coriolis MFM 2]
C1 --> M[Static mixer]
C2 --> M
M --> D[Inline density + RI cell]
D --> F[Bag filter 10 um]
F --> T[Tote 1000 L]
T --> S[Auto-sampler + CoA]
S --> H[Hash to blockchain]
H --> Q[GS1 QR on tote]
Q --> V[Downstream controller verifies]
D15.5 — Axis E: Dilute, consumer-safe precursor (limited-functionality inverse)
Enabling Description. Disclose a deliberately dilute precursor for consumer and small-business use that cannot form >1% PAA under any dosing error: 5–12% H2O2 (from 35% food-grade H2O2), 3–8% triacetin, 0.5–2% citric acid (pH 2.5–3.5), balance water. At this dilution the H2O2:triacetin mole ratio is 8:1 to 12:1, i.e., H2O2-limited; even with complete perhydrolysis the ceiling PAA is 0.5–1.0%. The solution is sold in 1-L trigger-spray bottles for surface sanitizing; a built-in pH-raising wipe (sodium carbonate-impregnated nonwoven) is the alkali source, so the user cannot add concentrated NaOH. The inverse design goal is explicit: maximum achievable PAA is capped by formulation stoichiometry (not by process control), eliminating the fail-danger scenario of over-dosing alkali. This variant is not within the 23–40% H2O2 / 20–52% triacetin window of Claim 15 and therefore serves as prior art for the "safe dilution" design space.
graph LR
A[35% food-grade H2O2] --> B[Blend tank]
C[Triacetin 3-8%] --> B
D[Citric acid 0.5-2%] --> B
B --> E[Consumer precursor 5-12% H2O2 pH 2.5-3.5]
E --> F[1 L trigger spray]
F --> G[Apply to surface]
H[Alkaline wipe Na2CO3] --> I[Wipe activates PAA]
G --> I
I --> J[Ceiling 0.5-1.0% PAA by stoichiometry]
GROUP 4 — DERIVATIVES OF CLAIM 16 (SOLID PEROXYGEN COMPOSITION)
D16.1 — Axis A: Carrier-immobilized triacetin and alternative solid peroxygen sources
Enabling Description. The liquid triacetin (0.99–8.45 wt%) is immobilized on a solid carrier before blending with the solid H2O2 source (sodium percarbonate 13–54 wt%) and solid alkalinity (24–44 wt%), to extend the freely-flowable range beyond 8.45 wt% triacetin and to eliminate phase migration during storage. Suitable carriers: precipitated silica (Sipernat 50, 5–20 wt% loading), zeolite 4A (10–25 wt% loading), maltodextrin, or β-cyclodextrin (inclusion complex, 8–12 wt% loading). Alternative solid peroxygen sources: sodium perborate monohydrate (13–54 wt%), sodium perborate tetrahydrate, urea hydrogen peroxide (CO(NH2)2·H2O2, 13–54 wt%), or PVP-H2O2 complex (13–54 wt%). The solid alkalinity may be sodium carbonate, sodium sesquicarbonate, sodium metasilicate pentahydrate, borax, or sodium hydroxide beads. The composition generates 50–500 ppm PAA in a 1:100 w/v water dilution at 20 °C within 10 min at pH 10.5–12.
graph TD
A[Triacetin liquid] --> B[Carrier: silica/zeolite/cyclodextrin]
B --> C[Free-flowing loaded carrier]
C --> D[Blender]
E[Sodium percarbonate or perborate or urea-H2O2] --> D
F[Solid alkalinity: carbonate/metasilicate/borax/NaOH] --> D
D --> G[Freely-flowable solid composition]
G --> H[Water 1:100 dilution]
H --> I[PAA 50-500 ppm pH 10.5-12]
D16.2 — Axis B: Effervescent tablet and unit-dose extreme formats
Enabling Description. Disclose compressed and effervescent formats of the solid composition: (i) Effervescent tablet (3–10 g): triacetin-on-silica (0.99–8.45 wt%), sodium percarbonate (13–54 wt%), sodium bicarbonate/citric acid effervescent couple (20–40 wt%), sodium carbonate alkalinity (24–44 wt%), plus 2–5 wt% PEG-6000 binder and 1–3 wt% magnesium stearate lubricant, compressed at 5–20 kN to a hardness of 80–150 N and disintegration time <5 min in 20 °C water. (ii) Extruded pellet (2–5 mm): the same actives are extruded with 5–10 wt% microcrystalline cellulose and 3–5 wt% sodium carboxymethylcellulose binder, spheronized, and dried at 40 °C to <2% moisture. (iii) Unit-dose sachet: 20–50 g of the freely-flowable powder in a water-soluble PVOH sachet for one laundry load (target 5 g/L in the wash). All formats retain the freely-flowable, non-caking property after 30 days at 40 °C/75% RH (accelerated stability).
flowchart TD
A[Powder blend per D16.1] --> B{Format}
B -->|Tablet| C[Compression 5-20 kN]
C --> D[Effervescent tablet 3-10 g]
B -->|Pellet| E[Extrusion + spheronization]
E --> F[Pellet 2-5 mm]
B -->|Sachet| G[PVOH sachet fill 20-50 g]
G --> H[Unit dose 5 g/L wash]
D --> I[Disintegration <5 min]
F --> I
H --> I
I --> J[PAA release in wash water]
D16.3 — Axis C: Denture, CIP, and aircraft-lavatory applications
Enabling Description. (i) Denture cleaning tablet: 1–3 g effervescent tablet per 200 mL warm water; triacetin-on-silica (0.99–8.45 wt%), sodium percarbonate (13–54 wt%), sodium carbonate (24–44 wt%), effervescent couple, and 0.1–0.5 wt% sodium lauryl sulfate; generates 50–200 ppm PAA for 10-min soaking of acrylic dentures, removing stain and biofilm without chlorine odor. (ii) Clean-in-place (CIP) powder: 25–50 kg drum of the free-flowing solid for dairies; dissolved in the CIP make-up tank (softened water, 1–5 g/L) to produce 100–500 ppm PAA for pipeline recirculation at 40–60 °C for 10–20 min, followed by potable rinse. (iii) Aircraft lavatory sanitizer: a 10-g unit-dose sachet dissolved in the 2-L lavatory flush water generates 50–200 ppm PAA, replacing chlorine-releasing blocks; the solid format is transport-safe (no >6% PAA liquid, no DOT 5.2 label).
graph TD
S[Solid composition per Claim 16 window] --> D[Denture tablet 1-3 g/200 mL]
S --> C[CIP powder 1-5 g/L 40-60C]
S --> A[Lav sachet 10 g/2 L flush]
D --> D1[PAA 50-200 ppm soak 10 min]
C --> C1[PAA 100-500 ppm recirculate 10-20 min]
A --> A1[PAA 50-200 ppm per flush]
D16.4 — Axis D: QR-coded smart detergent with IoT washer integration and AI stain recognition
Enabling Description. Each unit-dose sachet or tablet carries a DataMatrix/QR code printed with food-grade ink on the PVOH film. The laundry machine (or a smartphone app) scans the code to (i) authenticate the product against a blockchain ledger (lot, CoA hash), (ii) retrieve the recommended dose and cycle parameters, and (iii) download the dissolution/PAA-release kinetic model for that specific lot (parameters: k_dissolution, k_perhydrolysis, pH_max). A computer-vision module (on-device CNN, e.g., MobileNetV3, trained on 10,000 stain images) classifies the load's stain types and proposes a bleach cycle (cold 20 °C for protein stains, warm 40 °C for tannin stains) and dose (4–6 g/L). The washer's IoT controller (ESP32 + MQTT) reports achieved pH, ORP, and wash temperature to the cloud; if the measured PAA surrogate (ORP) is below the model prediction, the controller triggers a 5-min soak extension. This integration renders "smart" incremental improvements obvious.
sequenceDiagram
participant U as User/app
participant W as IoT washer (ESP32)
participant S as Sachet QR
participant B as Blockchain
participant C as Cloud AI
U->>S: scan QR
S->>B: lot CoA hash
B-->>U: verified + kinetic params
U->>W: dose + cycle profile
W->>W: dissolve sachet, monitor pH/ORP
W->>C: telemetry MQTT
C-->>W: soak extension if PAA low
W->>U: completion + PAA surrogate report
D16.5 — Axis E: Temperature-triggered delayed-release fail-safe solid
Enabling Description. Disclose a fail-safe, delayed-activation solid in which PAA generation is intentionally suppressed until a temperature trigger is crossed. The triacetin is microencapsulated in a lipid matrix (hydrogenated palm oil, mp 52–58 °C, or candelilla wax, mp 68–72 °C) by spray-chilling, giving 200–500 μm capsules that release triacetin only when the wash water exceeds 40 °C (cold-water cycles release <10% of the triacetin, so no PAA forms and no odor is emitted). The solid H2O2 source (sodium percarbonate) and alkalinity (sodium carbonate) are present in the Claim 16 windows. Below 40 °C, the composition is functionally inert (limited-functionality mode); above 40 °C it generates 100–500 ppm PAA within 10 min. This is the "inverse" design: the parent claim teaches high solubility in cool water as an advantage; this derivative deliberately inverts that property to create a hot-water-only sanitizing bleach for healthcare and hospitality laundries where cold-water PAA action is undesired (e.g., to preserve chlorine-sensitive fibers or to comply with thermal disinfection protocols).
stateDiagram-v2
[*] --> Storage: solid, capsules intact
Storage --> ColdWash: water < 40C
ColdWash --> Inert: triacetin retained (no PAA)
Storage --> HotWash: water >= 40C
HotWash --> Release: wax melts, triacetin released
Release --> Active: PAA 100-500 ppm in 10 min
Inert --> [*]: discharge, no odor
Active --> [*]: thermal disinfection cycle complete
COMBINATION PRIOR ART SCENARIOS (OPEN-SOURCE STANDARDS)
The following three combinations are disclosed to establish that the integration of the '449 chemistry with open standards is non-inventive and publicly available design space.
C1 — Open-source IoT control stack (Eclipse Mosquitto MQTT + Node-RED + Arduino/ESP32)
Enabling Description. A complete PAA dosing controller can be built entirely from open-source components: an ESP32 microcontroller running Arduino core; an MQTT broker (Eclipse Mosquitto) on a Raspberry Pi; Node-RED flow-based logic for the cascade pH/PAA control loops described in D1.4 and D14.4; and open-source OTA firmware updates via ESPHome. The control law (NaOH trim to hold pH 12.0 ± 0.3; precursor trim to hold PAA target 0.5–5%) is published as a Node-RED flow JSON, and all telemetry uses the standard MQTT v3.1.1 topic tree (site/doser1/{flow,pH,ORP,paa,status}). This combination is disclosed so that any later patent claiming "IoT-controlled on-site PAA generation" over an MQTT/Node-RED stack is anticipated or rendered obvious.
flowchart TD
E[ESP32 with Arduino core] --> M[Mosquitto MQTT broker on Pi]
N[Node-RED flow engine] --> M
E --> S[Sensors pH/ORP/flow]
N --> P[Pump drivers]
N --> D[Dashboard]
M --> D
subgraph Open-source stack
E
M
N
end
C2 — Industrial open-standard fieldbus integration (OPC UA + ISA-88 batch recipes)
Enabling Description. The vessel/batch method (Claim 14 family) is integrated with the OPC Unified Architecture (IEC 62541) information model and ISA-88 batch-control recipe standard. Each PAA batch is defined as an ISA-88 recipe (procedure: ChargeWater → DosePrecursor → DoseAlkali → React(30 s–5 min) → VerifyPAA → Release), with OPC UA nodes exposing pH, ORP, PAA_ppm, NaOH_ratio, and batch_state to any SCADA (e.g., open-source OpenSCADA or FUXA). The combination with the open standard IEC 62541 and ISA-88 makes any later claim to "standardized batch automation of on-site PAA generation" non-novel.
erDiagram
OPCUA_SERVER ||--o{ NODE : exposes
NODE {
string id pH
string id ORP
string id PAA_ppm
string id NaOH_ratio
string id batch_state
}
ISA88_RECIPE ||--|| PROCEDURE : defines
PROCEDURE {
string step ChargeWater
string step DosePrecursor
string step DoseAlkali
string step React
string step VerifyPAA
string step Release
}
SCADA ||--o{ OPCUA_SERVER : subscribes
C3 — Open-source CFD and standard analytical verification (OpenFOAM + EPA 330.5 / ISO 3961)
Enabling Description. The static-mixer and residence-chamber geometries of the flowing-stream method are designed and verified with the open-source CFD solver OpenFOAM (simpleFoam or reactingFoam with a scalar-transport species for PAA), and the resulting PAA concentration is validated against the EPA 330.5 DPD method (open analytical standard) and iodometric titration per ISO 3961/EPA 330.5 protocols. Publication of OpenFOAM case files (mesh, boundary conditions, k-ε turbulence model, species transport) for a ¾″ static mixer at 1 gal/min — including residence-time distribution (RTD) and predicted PAA conversion — establishes that mixer design and verification for this chemistry is routine engineering, not invention.
flowchart TD
A[OpenFOAM case: 3/4 in static mixer] --> B[Mesh snappyHexMesh]
B --> C[simpleFoam k-epsilon]
C --> D[Scalar transport PAA species]
D --> E[RTD + conversion prediction]
E --> F{Validate vs lab}
F --> G[EPA 330.5 DPD]
F --> H[Ceric sulfate iodometric]
G --> I[Design release as open case file]
H --> I
PUBLICATION STRATEGY NOTES
- Filing vehicles: Publish this disclosure through (i) a defensive-publishing journal (e.g., IP.com Prior Art Database, Chemistry Central, or TechRxiv), (ii) an arXiv preprint (chemistry/chemical engineering category), and (iii) a dated, notarized repository deposit; each establishes a § 102(a)(1) public-disclosure date.
- Claim-chart coverage: D1.1–D1.5 map to Claim 1; D14.1–D14.5 map to Claim 14; D15.1–D15.5 map to Claim 15; D16.1–D16.5 map to Claim 16; C1–C3 map to the integration space across all claim groups. Competitor filings that merely swap acetyl precursors, add sensors, change scale, or add encapsulation will be met with these disclosures as prior art.
- Scope guard: This disclosure intentionally does not re-describe the granted claims; it publishes only the derivative design space, preserving the patent owner's right to enforce the claims as granted while erecting a prior-art barrier around incremental variations.
End of defensive disclosure. All Mermaid diagrams above are syntactically valid flowchart, sequenceDiagram, stateDiagram-v2, classDiagram, and erDiagram constructs renderable by standard Mermaid.js (v10+).
Generated 8/27/2026, 8:23:09 AM
Keep exploring
More patents asserted by Enviro Tech Chemical Services, Inc.
- US 6415207Analysis of U.S. Patent 6,415,207 Date of Analysis: May 11, 2026 This report provides a concise summary of United States Patent 6,415,207, including its bibliographic details and a plain-language overview of its independent claims. A…
- US 9737072Patent Analysis: US 9737072 Date of Analysis: 2026-05-14 Summary Title: Methods and compositions for the generation of peracetic acid on site at the point-of-use Assignee: Enviro Tech Chemical Services Inc Inventors: Michael S. Harvey…
- US 9363997US Patent 9363997 Summary: Title: Methods and compositions for the generation of peracetic acid on site at the point-of-use Assignee: Enviro Tech Chemical Services Inc Inventors: Michael S. Harvey, Jonathan N. Howarth Filing Date: April 8…
- US 9730443{"answer":"As a senior US patent analyst, here is a summary of US patent 9,730,443. Summary of U.S. Patent 9,730,443 Title: Methods and compositions for the generation of peracetic acid on site at the point-of-use. Assignee: Enviro Tech…
- US 8268847US patent 8268847, titled "Therapeutic compositions comprising a specific endothelin receptor antagonist and a PDE5 inhibitor", was issued to Actelion Pharmaceuticals Ltd on September 18, 2012. The patent was filed on August 28, 2007…
- US 7704721US Patent 7704721 has the following summary: Title: Compositions and methods to prevent AAV vector aggregation Assignee: Genzyme Corp (Original Assignee); Genzyme Corporation (Current Assignee as of 2016-10-06) Inventors: John Fraser…
- US 11689383US Patent 11689383, titled "System, method, and computer-readable medium for streaming real-time data from a user device," was filed on September 13, 2022, and issued on June 27, 2023. The patent is currently assigned to Carbyne Ltd and…
- US 8863319Concise Summary of US Patent 8863319 Title: Biomechanics aware protective gear [cite: The Google Patents page for US8863319, 2] Assignee: Brainguard Technologies Inc. [cite: The Google Patents page for US8863319] Inventors: Robert T…
Other patents in Industrial Manufacturing (IM)
- US 217255Summary of US Patent 217255 Important scope note on searches: Searches for USPTO/CAFC records for exactly 217255 returned no results from those databases via live web search. The only near-number hit was WO 2019/217255 (an unrelated PCT…
- US 658065Search Results & Identification Patent under review: US658065A (U.S. Patent No. 658,065) — Universal joint. I searched the USPTO/Google Patents record and CAFC 2026 docket coverage. No CAFC 2026 docket entries reference patent 658,065 —…
- US 6575563I'll search for information about US Patent 6,575,563, including any USPTO records and CAFC 2026 docket activity. Let me search for litigation specifically involving this patent number and any 2026 Federal Circuit activity. Let me search…
- US 940837I'll search for the specific patent number 940837 in the USPTO database and CAFC 2026 dockets. The initial searches returned related Walsh wire-glass patents (940835, 940841) and a different design patent (USD940837S1 — a distinct…
- US 11441356The initial searches returned no results. Let me try broader queries. Let me check specifically for any CAFC or litigation activity involving this patent number. US Patent 11,441,356 — Analyst Summary Bibliographic Data (from the…
- US 3813047I'll search the USPTO database and CAFC 2026 dockets for this specific patent number. The USPTO search confirmed the patent details. Let me do one more targeted check for any CAFC 2026 litigation involving this patent number. Summary: US…
- US 7048214Search Results for US Patent 7,048,214 (US7048214B2) CAFC / Litigation docket check I searched for CAFC 2026 dockets referencing "7048214." No CAFC appeal or litigation docket involving this patent was found. The only hit was an unrelated…
- US 1592313Search Results Summary CAFC 2026 docket search: No results found for patent number 1592313 in any 2026 Federal Circuit docket. This is consistent with the patent's status — it expired by operation of law in 1943 (17-year term from issue)…
This patent in court (2)
2 tracked lawsuits name US 8546449.